Massive newborn screening aims to catch rare diseases early
NCT ID NCT04393701
First seen Oct 01, 2025 · Last updated May 07, 2026 · Updated 34 times
Summary
This study will test 100,000 newborns in Normandy, France, for two rare genetic diseases (MPS1 and Pompe disease) using a blood spot test. The goal is to see how common these diseases are and to improve early detection. Parents must give permission for their baby to join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SCREENING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Caen University Hospital
RECRUITINGCaen, France
Contact
-
Rouen University Hospital
RECRUITINGRouen, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.